EGF and acquired polycythemia vera: Counter to this notion, we found that GRO-α (CXCL1) levels were markedly raised in ET patients compared to other MPNs, while EGF and eotaxin (CCL11) were higher in both ET and PV compared to MF patients (Fig. 2A).